China Rare Epilepsies Therapeutics Market


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: China
  • Report ID : 1604

  • Format: PPT, PDF

China Rare Epilepsies Therapeutics Market: Segmented by Drug Type (Sodium Valproate, Carbamazepine, Lamotrigine, and Topiramate), Surgery, Route of Administration (Oral and Parenteral), Distribution Channels (Online, Hospital and Retail Pharmacies)- Size, Share, Growth, Trends, and Forecasts (2020 – 2028)

SKU: 1604 Categories: ,

Report Overview

China Rare Epilepsies Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.1% during the forecast period.

Epilepsy is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, and sometimes loss of awareness. In China, reported estimates of the prevalence of active epilepsy vary from 0.48 to 8.51 per 1,00,000. While the estimated incidence rate is between 0.22 to 0.29 per 1,00,000. In China, it is estimated that there are approximately 9 million patients with epilepsy, approximately 60% of whom are affected by partial-onset seizures.

Market Drivers

China is a growing market for rare epilepsies due to factors such as rise in the China’s incidence rate of epilepsy (0.22 to 0.29 per 1,00,000). In addition to this the other factors that contribute to the growth of the market are rise in healthcare expenditure, increase in awareness and availability of cost-effective treatments. In China it was estimated that the number of people with epilepsy in China is almost 9 million with a treatment gap of 63%. This cost-effective approach was successful in reducing the treatment gap by about 13%.

However, there are some restraining factors for the growth of the rare epilepsy’s therapeutics market in China such as lack of proper healthcare infrastructure in rural areas and also due to the social stigma attached to the disorder.

1. China Rare Epilepsies Therapeutics Market Overview………………………………………
A. Market Size
2. Market Growth Drivers………………………………………………………………………
A. Increase in Incidence Rate
B. Increase in Awareness
C. Availability of Cost-Effective Treatments
D. Rise in Healthcare Expenditure
3. Types of Rare Epilepsies Based on Seizures…………………………………………………..
A. Generalized Epilepsy
B. Focal Epilepsy
C. Generalized and Focal Epilepsy
D. Others
4. Rare Epilepsies Therapeutics Market Segmentation……………………………………
A. By Drug Type
I. Sodium Valproate
II. Carbamazepine
III. Lamotrigine
IV. Topiramate
B. By Surgery
C. By Route of Administration
I. Oral
II. Parenteral
D. By Distribution Channels
I. Online Pharmacies
II. Hospital Pharmacies
III. Retail Pharmacies
5. Rare Epilepsies Major Products Market Share…………………………………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape………………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………………
A. GlaxoSmithKline Company Overview, Product & Services, Strategies & Financials
B. Eisai Company Overview, Product & Services, Strategies & Financials
C. UCB Pharma Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………….
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Rare Epilepsies Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Type:

On the basis of drug type, the China rare epilepsies therapeutics market can be segmented into Sodium Valproate, Carbamazepine, Lamotrigine, and Topiramate.

Antiepileptic drugs are used as first line treatment. AEDs work by changing the levels of chemicals in your brain. They do not cure epilepsy, but can stop seizures happening. These include Sodium Valproate, Carbamazepine, Lamotrigine, and Topiramate.

By Surgery:

Surgery to remove part of your brain may be an option if: AEDs are not controlling your seizures. Tests show that your seizures are caused by a problem in a small part of your brain that can be removed without causing serious effects.

By Route of Administration:

On the basis of route of administration, the China rare epilepsies therapeutics market can be segmented into oral and parenteral. Oral route of administration will dominate the market during the forecast period due to most of the first line drugs being given by oral route of administration. But in case of acute conditions the parenteral route of administration is preferred.

By Distribution Channels:

On the basis of distribution channels, the China rare epilepsies therapeutics market can be segmented into online pharmacies, hospital and retail pharmacies. Retail pharmacies will dominate the market during the forecast period due to easy availability of medicines. Online pharmacies are evolving nowadays and some patients prefer online pharmacies for the purchase of medicines. The medicines are available at a discounted price in online pharmacies as compared to other (hospital and retail pharmacies).

Major Players

Some of the key players in China’s rare epilepsies therapeutics market are GlaxoSmithKline PLC; Eisai (China) Pharmaceutical co. ltd; UCB Pharma (Zhuhai) Co. Ltd; Sihuan Pharmaceutical Holdings Group Ltd.

Key players are adopting strategies such as mergers and acquisitions, partnerships, agreements and regional expansion along with an increased focus on R&D to stand out as strong competitors in the market. For instance, Dainippon Pharmaceutical and Eisai Conclude Agreement for the Development, Manufacture and Marketing of the Anti-Epileptic Agent Zonisamide in China and other countries.

Eisai received a New Drug Approval for its in-house discovered and developed antiepileptic drug (AED) Fycompa (Perampanel) from the China National Medical Products Administration (NMPA) for use in an adjunctive treatment of partial onset seizures.

UCB announced it has received an Import Drug License (IDL) from the National Drug Administration of China (CNDA), creating a pathway to make VIMPAT (Lacosamide) available to treat people living with epilepsy in China.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements